Get a deeper insight into the potential performance of Inogen (INGN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for so
Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.
Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Names Michael Bourque as New Chief Financial Officer.
Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength dow
Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.
Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the compan
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil
Despite higher international business-to-business sales and rental revenues, Inogen's (INGN) overall third-quarter results reflect soft performances.
Inogen, Inc. (NASDAQ:INGN ) Q3 2023 Results Conference Call November 7, 2023 5:00 PM ET Company Participants Marissa Bych - IR Gilmartin Group Nabil Shabshab - President and CEO Mike Sergesketter - In
Inogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co
Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.
Inogen's (INGN) latest acquisition is expected to expand its global Respiratory Care presence and potentially address a large growing bronchiectasis market.
Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall second-quarter results reflect soft performances.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE